Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. US Food and Drug administration (FDA). Highlights of prescribing information votrient. 2012.
2. European Medicines Agency (EMA). Summary of product characteristics votrient. 2016.
3. US Food and Drug administration (FDA). Clinical pharmacology and biopharmaceutics review votrient. 2009.
4. Deng Y, Sychterz C, Suttle AB, Dar MM, Bershas D, Negash K, et al. Bioavailability, metabolism and disposition of oral pazopanib in patients with advanced cancer. Xenobiotica. 2013;43:443–53.
5. Herbrink M, Nuijen B, Schellens JHM, Beijnen JH. Variability in bioavailability of small molecular tyrosine kinase inhibitors. Cancer Treat Rev. 2015;41:412–22.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献